设为首页 |  加入收藏
首页期刊介绍编委会投稿须知通知公告刊登文章继续教育园地协办单位联系我们广告合作
公告栏:
我院生殖中心不孕不育患者的超说明书用药分析
作者:林芸1  李庆南1  林沛鸿1  陈浩浩2 
单位:1. 汕头市中心医院, 广东 汕头 515000;
2. 汕头大学医学院第一附属医院, 广东 汕头 515000
关键词:超说明书用药 生殖医学 不孕不育 合理用药 
中图分类号:R95
文献标志码:
出版年,卷(期):页码:2017,27(1):48-51,
收稿日期:2016-9-12
摘要:
目的 了解我院生殖中心不孕不育患者的超说明书用药的发生率及特点,为临床合理用药提供参考。方法 采用回顾性分析,抽取我院2015年10月1日至12月31日生殖中心的所有门诊患者处方,记录患者的基本信息、临床诊断和用药信息等内容,筛选出临床诊断包含不孕或不育,年龄≤45 a的病例,根据药品说明书,由两名药师共同判断超说明书用药类型,并进行统计分析。结果 共筛选出处方4 437张,含6 889条用药医嘱,其中含有超说明书用药的处方1 221张,占27.5%;有1689条超说明书用药医嘱,占24.5%;类型为超适应症1 045条(61.9%),超用法用量461条(27.3%),超给药途径22条(1.3%),超适应症同时超用法用量161条(9.5%)。超说明书用药使用频率高的药品主要为激素类和影响代谢类等药物。结论 我院生殖中心不孕不育患者超说明书用药现象普遍,药事管理部门应规范其使用,临床医生和药师应收集循证医学证据,提高合理用药水平。
OBJECTIVE To determine the prevalence and characteristic of off-label drug use in our hospital's infertility outpatients,and to provide a reference for clinical rational drug use. METHODS Retrospective analysis was used for this study. Infertility outpatient prescriptions (October 1,2015 to December 31,2015) were included. The basic information,clinical diagnosis and treatment information of each prescription was recorded,and prescriptions with diagnosis containing infertility and age below 45 years old were screened out for this study. According to the summary of product characteristics,natures of off-label drug use were distinguished by two pharmacists. RESULTS 4 437 infertility outpatient prescriptions were enrolled,which included 6889 medication orders. 1 221 prescriptions (27.5% of the total prescriptions) contained at least one off-label drug use,. 1689 medication orders (24.5% of total) were used off label. The categories were indication(1045/1689,61.9%),dose (461/1689,27.3%),administration route (22/1689,1.3%) and indication with dose(161/1689,9.5%),which were not recommended in the summary of product characteristics. Hormones and affect metabolism drugs were the most common off-label use. CONCLUSION Off-label drug use is very common in infertility outpatients. In order to promote rational drug use,pharmacy departments should regulate their use,and clinicians and pharmacists should collect evidence based medicine.
基金项目:
作者简介:
林芸,主管药师,研究方向:医院临床药学,Tel:0754-88903044,E-mail:linyun08668@163.com
通讯作者:
参考文献:
[1] 王海翔. 不孕不育的致病因素及其护理[J]. 世界最新医学信息文摘,2015,15(93):16-18.
[2] 杨菁,张燕. 不孕症研究概况[J]. 国外医学妇幼保健分册,2005,16(4):232-235.
[3] Mahmoud Chehab,Alosh Madala,J.C. Trussell,et al. On-label and off-label drug used in the treatment of male infertility[J]. Fertility and Sterility,2015,103(3):595-604.
[4] 广东省药学会. 药品未注册用法专家共识[J]. 今日药学,2010,20(4):1-3.
[5] 广东省药学:会风湿免疫用药专家委员会. 风湿免疫疾病(类风湿关节炎)超药品说明书用药专家共识[J]. 今日药学,2014,24(9):625-629.
[6] 刘铎,吴东媛,刘朦朦,等. 全球肿瘤患者超说明书用药现状的系统评价[J]. 中国循证医学杂志,2015,15(5):508-513.
[7] E Kimland,V Odlind. Off-Label Drug Use in Pediatric Patients[J]. Clinical Pharmacology and Therapeutics,2012,91(5):796-801.
[8] 谷宏伟,马满玲,杨丽杰,等. 老年人超说明书用药情况调查[J]. 实用药物与临床,2015,18(3):370-373.
[9] Rebecca S. Usadi,Kathryn S. Merriam. On-label and off-label drug used in the treatement of female infrtility[J]. Fertility and Sterility,2015,103(3):583-594.
[10] Ali A. Dabaja,Peter N. Schlegel. Medical treatment of male infertility[J]. Translational Andrology and Urology,2014,3(1):9-16.
[11] 杨明根,郑周达,许振强,等. 辅酶Q10治疗特发性少弱畸形精子症有效性与安全性的Meta分析[J]. 中国循证医学杂志,2016,16(9):1090-1096.
[12] Mohammad Reza Safarine jad. The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia:an open-label prospective study[J]. International Urology and Nephrology,2012,44(3):689-700.
[13] Moradan S,Ghorbani R. Dexamethasone in unexplained infertility[J]. Saudi Medical Journal,2009,30(8):1034-1036.
[14] W Raber,P Nowotny,E.Vytiska-Binstorfer,et al. Thyroxine treatment modified in ingfertile women according to thyroxine-releasing hormone testing:5 year follow-up of 283 women referred after exclusion of absolute causes of infertility[J]. Human Reproduction,2003,18(4):707-714.
[15] 王丽,李锡梅,喻琳麟. 甲状腺素水平异常与不孕关系的初探[J].四川医学,2013,34(3):324-326.
[16] 乔杰,马彩虹,刘嘉茵,等. 辅助生殖促排卵药物治疗专家共识[J].生殖避孕,2015,35(4):211-223.
[17] 林静,李廉,郑惠冰,等. 给予阴道溴隐亭治疗妇科高泌乳素血症的效果分析[J]. 中国实用医药,2012,7(31):152-153.
[18] Introduction:On-label and off-label drug use in reproductive medicine[J]. Fertility and sterility,2015,103(3):581-582.
[19] Off-label prescribing in pregnancy-a case of risky business or business as usual[J]. European Journal of Obstetric & Gynecology and Reproductive Biology,2015,187(1):78-79.
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
广东今日药学杂志社有限公司   地址:广州市东风东路753号东塔7楼702
电话:020-37886325       邮箱:jinriyaoxue@163.com
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
粤ICP备20054928号

粤公网安备 44010402002138号

您是第 165078 位访问者